Xiaolin Lin
Impact in
- Cancer Research top 10%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
-
- Cancer Immunotherapy and Biomarkers
Papers in
-
- Cancer, Lipids, and Metabolism 2
- Oncology 6
- Co-authors
- Xiuying Xiao (14 shared papers)Ruizhe Shen (2 shared papers)Shidan Cheng (1 shared paper)Qi Xu (4 shared papers)Jie Hong (3 shared papers)Haoyan Chen (2 shared papers)Ting Han (2 shared papers)Lisha Wang (2 shared papers)
- Journals
- Journal of Cancer (2 papers)Transplant Immunology (2 papers)PLoS ONE (2 papers)Endocrine Practice (1 paper)Cell Death and Disease (1 paper)
- Partner nations
- ChinaGermanyUnited States
In The Last Decade
Xiaolin Lin
31 papers receiving 977 citations
Xiaolin Lin's Hit Papers
Peers
Comparison fields: 5 of 82
- Cancer Research 239
- Oncology 214
- Biological Psychiatry 19
- Biotechnology 70
- Molecular Biology 543
Countries citing papers authored by Xiaolin Lin
This map shows the geographic impact of Xiaolin Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaolin Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaolin Lin more than expected).
Fields of papers citing papers by Xiaolin Lin
This network shows the impact of papers produced by Xiaolin Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaolin Lin. The network helps show where Xiaolin Lin may publish in the future.
Co-authors
The 25 scholars most cited alongside Xiaolin Lin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 33 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Fusobacterium nucleatum-derived succinic acid induces tumor resistance to immunotherapy in colorectal cancer Hit paper breakdown → | 2023 | 312 |
| 2 | 2010 | 129 | |
| 3 | 2023 | 82 | |
| 4 | 2022 | 48 | |
| 5 | 2024 | 47 | |
| 6 | 2020 | 39 | |
| 7 | 2021 | 37 | |
| 8 | 2017 | 32 | |
| 9 | 2009 | 30 | |
| 10 | 2014 | 29 | |
| 11 | 2020 | 22 | |
| 12 | 2015 | 21 | |
| 13 | 2017 | 20 | |
| 14 | 2022 | 17 | |
| 15 | 2014 | 17 | |
| 16 | 2020 | 16 | |
| 17 | 2017 | 16 | |
| 18 | 2022 | 15 | |
| 19 | 2012 | 10 | |
| 20 | 2022 | 9 |
About Xiaolin Lin
Xiaolin Lin is a scholar working on Cancer Research, Oncology, Molecular Biology, Pulmonary and Respiratory Medicine and Cell Biology, having authored 33 papers that have together received 987 indexed citations. Recurring topics across this work include Immune Cell Function and Interaction (2 papers), Glycosylation and Glycoproteins Research (2 papers), Gastric Cancer Management and Outcomes (2 papers), Ferroptosis and cancer prognosis (2 papers), T-cell and B-cell Immunology (2 papers), Ginseng Biological Effects and Applications (2 papers), Extracellular vesicles in disease (2 papers) and Cancer, Lipids, and Metabolism (2 papers). The work is most often cited by research in Cancer Research (239 citations), Oncology (214 citations), Biological Psychiatry (19 citations), Biotechnology (70 citations) and Molecular Biology (543 citations). Xiaolin Lin has collaborated with scholars based in China, Germany and United States. Frequent co-authors include Xiuying Xiao, Ruizhe Shen, Shidan Cheng, Qi Xu, Jie Hong, Haoyan Chen, Ting Han, Lisha Wang, Yingxuan Chen and Jing‐Yuan Fang. Their work appears in journals such as Journal of Cancer, Transplant Immunology, PLoS ONE, Endocrine Practice and Cell Death and Disease.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.